Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
Sihuan Pharmaceutical Holdings Group Ltd. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Wan Chai, HK. The stock last traded at $0.12, up 0.00% on the session, giving a market capitalisation of $1.09B. On trailing twelve-month figures it carries a trailing P/E of 38.36, a net margin of 6.9%. Its beta of 0.89 implies it has historically moved less than the broad market.
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
Sihuan Pharmaceutical Holdings Group Ltd. is most often compared with the following Healthcare names: